The efficacy and safety of P2Y12 inhibitor monotherapy in patients after percutaneous coronary intervention

The optimal antiplatelet therapy after percutaneous coronary intervention (PCI) remains to be elucidated. Monotherapy with a P2Y12 inhibitor may be inferior to dual antiplatelet therapy in patients after PCI. PubMed, EMBASE (by Ovidsp), Web of Science, and The Cochrane Library were searched from dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Liman, Fu, Menglu, Li, Yuanyuan, Chen, Zhihui, Yu, Jing, Luo, Jinlan, Hu, Shuiqing, Tu, Ling, Xu, Xizhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2019
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068072/
https://www.ncbi.nlm.nih.gov/pubmed/31777973
http://dx.doi.org/10.1002/clc.23305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068072/
https://www.ncbi.nlm.nih.gov/pubmed/31777973
http://dx.doi.org/10.1002/clc.23305

Ejemplares similares